A groundbreaking shift in Canadian drug policy has occurred, as the government permit the use of psilocybin hallucinogens for therapeutic applications. Previously, these substances were strictly restricted, but a increasing body of studies suggests they may offer benefits for psychological conditions like PTSD. This change represents a key step tow